Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule with the chemical formula C26H23N5O and a molecular weight of approximately 421.49 g/mol. It contains an indole moiety fused to a benzene ring and features both pyridine and methoxy functional groups. The structure suggests it may have been designed for research targeting enzymes or receptors involving indole or pyridine recognition motifs. There is no evidence of clinical use or approval; it appears in chemical databases as an experimental entity only[1][3]. No specific mechanism of action, developer company, or primary indication has been reported in public sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE.